Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

2nd International Conference on Drug Discovery 2026

industry leaders, and academicians from around the world to explore groundbreaking innovations in drug research, pharmaceutical sciences, and biotechnology. The 2nd International Conference on Drug Discovery 2026, organized by Scisynopsis...

Digi-Tech Pharma & AI Conference 2026

The 9th Annual Digi-Tech Pharma & AI conference, a premier Pharmaceutical Technology Conference, brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare...

2nd Annual MaxPotent Pharma Summit 2026

leading international platform bringing together senior executives, regulatory authorities, technology providers, and pharmaceutical innovators dedicated to advancing the future of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). 2nd...

Approval and Launch of Nintedanib Capsules

"We are excited to bring Nintedanib Capsules to market, further strengthening Dexcel's growing portfolio of specialty pharmaceutical products. This approval reflects our commitment to providing high-quality, accessible treatment options for...

Thermo Fisher Scientific Unveils Integrated Platform to Enhance Biologics Development

them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher...

ProductLife Group Appoints Dr. James Burt as CEO

Burt as Chief Executive Officer. Dr. Burt brings more than 20 years of international leadership experience across the pharmaceutical value chain, including generics, biosimilars, orphan and value-added medicines. He has a strong track record in...

Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh...

Emerging From Stealth, Oryon Cell Therapies Targets Autologous Neuron Replacement for Parkinson’s Disease and Neurodegenerative Disorders

announced that it has appointed Ron Cohen, M.D., as Chief Executive Officer (CEO). Dr. Cohen is an accomplished biopharmaceutical entrepreneur, CEO, industry leader and advocate, with a 30-year record of value creation through development,...

Samsung Biologics Labor Union Warns of "Structural Supply Chain Risk" Amid Labor Dispute, Citing Systemic Governance Failures

a systemic failure that directly threatens the uninterrupted 24/7 continuous manufacturing required in the biopharmaceutical industry." Internal Documents: Unfair Labor Practices and Governance Interference The union argues that Chairman Jae-yong...

Convergent Therapeutics Appoints Michael Rossi to Board

the appointment of Michael Rossi to its Board of Directors. Mr. Rossi brings more than 30 years of experience in radiopharmaceuticals, drug development, and commercial leadership to Convergent, as the Company completes its Phase 2 study of...

Eton Pharmaceuticals Strengthens Rare Disease Portfolio with U.S. Commercialization Rights to HEMANGEOL® Oral Solution

Eton Pharmaceuticals, Inc an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced it has in-licensed U.S. commercialization rights to HEMANGEOL® oral solution from Pierre Fabre...

Ron Mayron Becomes Chairman of the Board of Matricelf Ltd

Bio, DNA Biomedical Solutions, and Earmada . His broad board level experience spans biotechnology, medical devices, pharmaceuticals, and advanced therapeutic platforms. In his eligibility declaration, Mr. Mayron confirmed that he meets the...

Unique Mouse Model Enables genOway to Transform Prediction of Antibody Therapies in Humans

biology, and human immunology. The achievement was made possible through an international consortium of leading biopharmaceutical partners, led by genOway, who combined their knowledge to co-develop and co-validate the genO-hFcγR mouse model....

ARUP Laboratories Establishes Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

laboratory in the U.S., announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners. The Innovation Central Laboratory will serve as an ecosystem for...

SECuRE trial update: Another participant with negative PSMA PET and undetectable PSA

Clarity Pharmaceuticals a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that yet another participant with mCRPC in the...

To strengthen global AI, data strategy, evidence synthesis, and economic modelling capabilities, Precision AQ expands its senior leadership team

choice for biopharma innovators, market access leaders, and brand strategists. Trusted by all 30 of the world's top pharmaceutical companies, and leading biotechs, we specialise in transforming complex data into clear, actionable strategies that...

New ECCO data demonstrate that subcutaneous infliximab (Remsima™ SC) recaptures and maintains disease control following a drug holiday

and corticosteroid-free remission generally maintained through Week. About Celltrion Celltrion is a leading biopharmaceutical company that specializes in researching, developing, manufacturing, marketing and sales of innovative therapeutics that...

Breakthrough in Zika Virus Drug Discovery Reported by IRBM

with a high-throughput screening (HTS) platform. Its mission is to act as a bridge between academic research and pharmaceutical development, with a particular focus on targeting rare, neglected, and poverty-related diseases. For more information...

A Breakthrough Study Confirms HYD LLC's 30-Year Research on Deuterium Modulation in Cancer Gene Expression.

regulator, capable of reprogramming gene expression in tumor cells. This discovery opens new horizons in oncology and pharmaceutical development: Deuterium modulation emerges as a novel therapeutic target—not merely a passive change in water...

FDA Grants KORU Medical Systems 510(k) Clearance for RYSTIGGO® Delivery via FreedomEDGE® Infusion System

professional. Through its Pharma Service and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of...